The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
International Journal of Molecular Sciences · 27.01.2023 · 24 (3) · 2477
DOI: 10.3390/ijms24032477 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.01.2023. Verfasst von Jacob S Deyell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Synucleinopathies. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, CurePSP.
Abstract (Originalsprache)
Synucleinopathies are a set of devastating neurodegenerative diseases that share a pathologic accumulation of the protein α-synuclein (α-syn). This accumulation causes neuronal death resulting in irreversible dementia, deteriorating motor symptoms, and devastating cognitive decline. While the etiology of these conditions remains largely unknown, microglia, the resident immune cells of the central nervous system (CNS), have been consistently implicated in the pathogenesis of synucleinopathies. Microglia are generally believed to be neuroprotective in the early stages of α-syn accumulation and contribute to further neurodegeneration in chronic disease states. While the molecular mechanisms by which microglia achieve this role are still being investigated, here we highlight the major findings to date. In this review, we describe how structural varieties of inherently disordered α-syn result in varied microglial receptor-mediated interactions. We also summarize which microglial receptors enable cellular recognition and uptake of α-syn. Lastly, we review the downstream effects of α-syn processing within microglia, including spread to other brain regions resulting in neuroinflammation and neurodegeneration in chronic disease states. Understanding the mechanism of microglial interactions with α-syn is vital to conceptualizing molecular targets for novel therapeutic interventions. In addition, given the significant diversity in the pathophysiology of synucleinopathies, such molecular interactions are vital in gauging all potential pathways of neurodegeneration in the disease state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA.
- UCI Institute for Neurotherapeutics, University of California, Irvine, CA 92697, USA.
- Virginia Commonwealth University School of Medicine, Richmond, VA 23223, USA.
- Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
ORCID-Profile: Jacob S Deyell, Manjari Sriparna, Mingyao Ying, Xiaobo Mao
Förderung
- NIH HHS
- NIA NIH HHS
- CurePSP
- NINDS NIH HHS
- Maryland Stem Cell Research Fund
- Parkinson's Foundation
- ADRC
- AFAR New Investigator Award in Alzheimer’s disease
Zitieren
APA
Deyell, J. S., Sriparna, M., Ying, M., & Mao, X. (2023). The Interplay between α-Synuclein and Microglia in α-Synucleinopathies. International Journal of Molecular Sciences, 24(3), 2477. https://doi.org/10.3390/ijms24032477
Vancouver
Deyell JS, Sriparna M, Ying M, Mao X. The Interplay between α-Synuclein and Microglia in α-Synucleinopathies. International Journal of Molecular Sciences. 2023;24(3):2477. doi:10.3390/ijms24032477
BibTeX
@article{Deyell2023,
author = {Deyell, Jacob S and Sriparna, Manjari and Ying, Mingyao and Mao, Xiaobo},
title = {The Interplay between α-Synuclein and Microglia in α-Synucleinopathies},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2477},
doi = {10.3390/ijms24032477}
}
EUVIMED